The size of your client representation and the magnitude of what the payer is willing to pay for may or may not be equal, and it`s important to have a clear understanding of both from the start. MPR 1.2 allows you to limit your representation of the client, provided that the restriction is appropriate in the circumstances and that the client has given informed consent. If your agreement with the client is tacit or ambiguous as to a limitation on the scope of your representation, this scope will be determined taking into account what the client would reasonably have foreseen in the circumstances. Conversations you had with the payer about the extent of the payer`s payment obligations in which the customer was not initiated would not be taken into account. Carefully crafted agreements with the client and payer reduce the chances that you will be forced to provide the client with a wider range of legal services than the payer has accepted. However, once the provider and the third-party payer have negotiated and executed the contract, the relationship between the payer and the payee runs smoothly. This may apply whether the negotiations were cooperative or contradictory. During the relationship, there can often be disputes over the terms of the third-party contract that the parties have worked so hard to negotiate and agree on. And since these disputes often concern the most critical provisions of the payment contract, it is more likely that both parties have a legitimate interest in finding a definitive solution in order to take legal action through public health disputes. A third party is another name of Impleader`s procedural apparatus used in a civil action by a defendant who wishes to bring a legal action, since that party is ultimately liable for all or part of the damage that can be attributed to the applicant. Sharing the client`s trust with the payer after the client has given informed consent fulfills your obligation of confidentiality, see MPR 1.6, but you should also consider attorney`s privilege when deciding what should be disclosed to the payer. .